Logo image of ZVIA

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

USA - NYSE:ZVIA - US98955K1043 - Common Stock

2.42 USD
+0.05 (+2.11%)
Last: 9/16/2025, 12:03:05 PM
Fundamental Rating

4

Overall ZVIA gets a fundamental rating of 4 out of 10. We evaluated ZVIA against 32 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. ZVIA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZVIA had negative earnings in the past year.
ZVIA had a negative operating cash flow in the past year.
ZVIA had negative earnings in each of the past 5 years.
In the past 5 years ZVIA always reported negative operating cash flow.
ZVIA Yearly Net Income VS EBIT VS OCF VS FCFZVIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -22.76%, ZVIA is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
ZVIA has a worse Return On Equity (-26.81%) than 84.38% of its industry peers.
Industry RankSector Rank
ROA -22.76%
ROE -26.81%
ROIC N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ZVIA Yearly ROA, ROE, ROICZVIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

ZVIA has a Gross Margin (49.25%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ZVIA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ZVIA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
ZVIA Yearly Profit, Operating, Gross MarginsZVIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZVIA has more shares outstanding than it did 1 year ago.
ZVIA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZVIA Yearly Shares OutstandingZVIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZVIA Yearly Total Debt VS Total AssetsZVIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 10.91 indicates that ZVIA is not in any danger for bankruptcy at the moment.
ZVIA has a better Altman-Z score (10.91) than 90.63% of its industry peers.
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.91
ROIC/WACCN/A
WACC8.7%
ZVIA Yearly LT Debt VS Equity VS FCFZVIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.34 indicates that ZVIA has no problem at all paying its short term obligations.
ZVIA has a better Current ratio (2.34) than 75.00% of its industry peers.
A Quick Ratio of 1.69 indicates that ZVIA should not have too much problems paying its short term obligations.
ZVIA has a Quick ratio of 1.69. This is amongst the best in the industry. ZVIA outperforms 84.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.69
ZVIA Yearly Current Assets VS Current LiabilitesZVIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

ZVIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.27%, which is quite impressive.
ZVIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.09%.
Measured over the past years, ZVIA shows a quite strong growth in Revenue. The Revenue has been growing by 12.62% on average per year.
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%10.14%

3.2 Future

The Earnings Per Share is expected to grow by 21.70% on average over the next years. This is a very strong growth
ZVIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.26% yearly.
EPS Next Y44.89%
EPS Next 2Y30.53%
EPS Next 3Y21.7%
EPS Next 5YN/A
Revenue Next Year4.21%
Revenue Next 2Y5.5%
Revenue Next 3Y6.26%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZVIA Yearly Revenue VS EstimatesZVIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ZVIA Yearly EPS VS EstimatesZVIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVIA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZVIA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZVIA Price Earnings VS Forward Price EarningsZVIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZVIA Per share dataZVIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ZVIA's earnings are expected to grow with 21.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.53%
EPS Next 3Y21.7%

More info and screens

0

5. Dividend

5.1 Amount

ZVIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEVIA PBC-A

NYSE:ZVIA (9/16/2025, 12:03:05 PM)

2.42

+0.05 (+2.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst Owners54.19%
Inst Owner Change14.48%
Ins Owners4.88%
Ins Owner Change-3.66%
Market Cap181.38M
Analysts80
Price Target4.96 (104.96%)
Short Float %3.94%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.88%
Min EPS beat(2)54.05%
Max EPS beat(2)77.72%
EPS beat(4)3
Avg EPS beat(4)42.41%
Min EPS beat(4)-12.04%
Max EPS beat(4)77.72%
EPS beat(8)7
Avg EPS beat(8)24.73%
EPS beat(12)11
Avg EPS beat(12)31.24%
EPS beat(16)13
Avg EPS beat(16)8.88%
Revenue beat(2)2
Avg Revenue beat(2)2.47%
Min Revenue beat(2)0.34%
Max Revenue beat(2)4.61%
Revenue beat(4)2
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)4.61%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-0.71%
PT rev (1m)9.16%
PT rev (3m)17.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.82%
EPS NY rev (1m)-8.77%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.15
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB 3.63
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.11
BVpS0.71
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.76%
ROE -26.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.25%
FCFM N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
F-Score5
Asset Turnover2.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.64%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 1.69
Altman-Z 10.91
F-Score5
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)104.57%
Cap/Depr(5y)142.96%
Cap/Sales(3y)0.92%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
EPS Next Y44.89%
EPS Next 2Y30.53%
EPS Next 3Y21.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%10.14%
Revenue Next Year4.21%
Revenue Next 2Y5.5%
Revenue Next 3Y6.26%
Revenue Next 5YN/A
EBIT growth 1Y60.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.6%
EBIT Next 3Y28.98%
EBIT Next 5YN/A
FCF growth 1Y2.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1406.88%
OCF growth 3YN/A
OCF growth 5YN/A